 GW Henssler Associates Ltd. lowered its position in shares of United Therapeutics Co. NASDAQ:UTHR by 5.5 in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,349 shares of the biotechnology companys stock after selling 255 shares during the quarter. GW Henssler Associates ... 